Inspire Medical Systems Inc
INSP95.390USD
-0.260-0.27%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
2.77BMarket Cap
63.63P/E TTM
More Details of Inspire Medical Systems Inc Company
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Inspire Medical Systems Inc Info
Ticker SymbolINSP
Company nameInspire Medical Systems Inc
IPO dateMay 03, 2018
CEOHerbert (Timothy P)
Number of employees1246
Security typeOrdinary Share
Fiscal year-endMay 03
Address5500 Wayzata Blvd Ste 1600
CityGOLDEN VALLEY
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code55416-1237
Phone17639575037
Websitehttps://www.inspiresleep.com/
Ticker SymbolINSP
IPO dateMay 03, 2018
CEOHerbert (Timothy P)
Company Executives of Inspire Medical Systems Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-79.27%
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
27.85K
-4.13%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.23K
+0.96%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-43.33%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
--
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.37K
+5.94%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-0.12%
Mr. John C. Rondoni
Mr. John C. Rondoni
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Carlton W. Weatherby
Mr. Carlton W. Weatherby
Chief Strategy and Growth Officer
Chief Strategy and Growth Officer
--
--
Ms. Georgia Garinoismelenikiotou
Ms. Georgia Garinoismelenikiotou
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-79.27%
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
27.85K
-4.13%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.23K
+0.96%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-43.33%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
--
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.37K
+5.94%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
207.15M
95.42%
All other countries
9.94M
4.58%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.30%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
William Blair Investment Management, LLC
4.47%
Other
63.29%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.30%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
William Blair Investment Management, LLC
4.47%
Other
63.29%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.25%
Hedge Fund
27.37%
Investment Advisor/Hedge Fund
25.26%
Research Firm
6.21%
Pension Fund
2.32%
Individual Investor
1.19%
Sovereign Wealth Fund
0.96%
Bank and Trust
0.81%
Venture Capital
0.42%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
828
32.29M
111.12%
-7.29M
2025Q2
883
35.48M
119.97%
-4.91M
2025Q1
912
35.71M
121.08%
-5.66M
2024Q4
874
35.22M
118.69%
-4.72M
2024Q3
852
35.48M
118.45%
-2.86M
2024Q2
825
33.60M
112.73%
-2.85M
2024Q1
801
33.20M
111.87%
-2.01M
2023Q4
786
32.35M
109.45%
+751.92K
2023Q3
753
29.93M
101.80%
-635.63K
2023Q2
727
29.57M
101.94%
-987.85K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
3.49M
11.8%
-108.13K
-3.00%
Jun 30, 2025
The Vanguard Group, Inc.
3.20M
10.81%
-22.12K
-0.69%
Jun 30, 2025
William Blair Investment Management, LLC
769.17K
2.6%
+76.25K
+11.00%
Jun 30, 2025
Baillie Gifford & Co.
1.11M
3.77%
-45.87K
-3.95%
Jun 30, 2025
State Street Investment Management (US)
1.03M
3.49%
+22.84K
+2.27%
Jun 30, 2025
Braidwell LP
522.41K
1.77%
+220.00K
+72.75%
Jun 30, 2025
Janus Henderson Investors
640.92K
2.17%
-1.84K
-0.29%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
2.68%
State Street SPDR S&P Health Care Equipment ETF
1.63%
Invesco S&P SmallCap Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.53%
iShares S&P Small-Cap 600 Growth ETF
0.43%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
0.27%
WisdomTree US SmallCap Quality Growth Fund
0.26%
View more
Global X HealthTech ETF
Proportion2.68%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.63%
Invesco S&P SmallCap Health Care ETF
Proportion1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.53%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.43%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proportion0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.27%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.26%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Inspire Medical Systems Inc?
The top five shareholders of Inspire Medical Systems Inc are:
BlackRock Institutional Trust Company, N.A. holds 3.49M shares, accounting for 11.80% of the total shares.
The Vanguard Group, Inc. holds 3.20M shares, accounting for 10.81% of the total shares.
William Blair Investment Management, LLC holds 769.17K shares, accounting for 2.60% of the total shares.
Baillie Gifford & Co. holds 1.11M shares, accounting for 3.77% of the total shares.
State Street Investment Management (US) holds 1.03M shares, accounting for 3.49% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.49M shares, accounting for 11.80% of the total shares.
The Vanguard Group, Inc. holds 3.20M shares, accounting for 10.81% of the total shares.
William Blair Investment Management, LLC holds 769.17K shares, accounting for 2.60% of the total shares.
Baillie Gifford & Co. holds 1.11M shares, accounting for 3.77% of the total shares.
State Street Investment Management (US) holds 1.03M shares, accounting for 3.49% of the total shares.
What are the top three shareholder types of Inspire Medical Systems Inc?
The top three shareholder types of Inspire Medical Systems Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Citadel Advisors LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Citadel Advisors LLC
How many institutions hold shares of Inspire Medical Systems Inc (INSP)?
As of 2025Q3, 828 institutions hold shares of Inspire Medical Systems Inc, with a combined market value of approximately 32.29M, accounting for 111.12% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -8.85%.
What is the biggest source of revenue for Inspire Medical Systems Inc?
In FY2025Q2, the -- business generated the highest revenue for Inspire Medical Systems Inc, amounting to -- and accounting for --% of total revenue.
